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ABSTRACT
Recently, much attention has been given to elucidate
how long-range gene regulation comes into play and
how histone modifications and distal transcription
factor binding contribute toward this mechanism.
Androgen receptor (AR), a key regulator of prostate
cancer, has been shown to regulate its target genes
via distal enhancers, leading to the hypothesis of
global long-range gene regulation. However,
despite numerous flows of newly generated data,
the precise mechanism with respect to
AR-mediated long-range gene regulation is still
largely unknown. In this study, we carried out an
integrated analysis combining several types of
high-throughput data, including genome-wide distri-
bution data of H3K4 di-methylation (H3K4me2),
CCCTC binding factor (CTCF), AR and FoxA1
cistrome data as well as androgen-regulated gene
expression data. We found that a subset of
androgen-responsive genes was significantly
enriched near AR/H3K4me2 overlapping regions
and FoxA1 binding sites within the same CTCF
block. Importantly, genes in this class were
enriched in cancer-related pathways and were
downregulated in clinical metastatic versus
localized prostate cancer. Our results suggest a
relatively short combinatorial long-range regulation
mechanism facilitated by CTCF blocking. Under
such a mechanism, H3K4me2, AR and FoxA1 within
the same CTCF block combinatorially regulate a
subset of distally located androgen-responsive
genes involved in prostate carcinogenesis.
INTRODUCTION
Androgens, functioning through the androgen receptor
(AR), are not only essential in sexual development of
males but also drive the onset and subsequent progression
of prostate cancer. As a result, androgen ablation has
been used as an effective ﬁrst-line therapy for treatment
of advanced androgen-dependent prostate cancer
(ADPC). However, ADPC will ultimately progress to an
AR-dependent, castration-resistant stage (CRPC) (1–3).
Despite the importance of AR in both ADPC and
CRPC, the precise mechanism by which AR regulates
AR-dependent genes remains unknown.
Recent developments of chromatin immunopre-
cipitation (ChIP) techniques followed by high-throughput
screening (e.g. ChIP-chip and ChIP-seq) have enabled
studies to map AR cistrome in prostate cancer. An im-
portant ﬁnding from these genome-wide studies is that
the majority of AR binding sites is located within non-
promoter regions such as enhancers. For instance, in
both ADPC (LNCaP and VCaP) and CRPC (LNCaP-
abl and C4-2B) cell models, over 85% of the
AR-binding sites are distal from AR-dependent genes
(4–6). These studies reinforce the concept that steroid re-
ceptors [e.g. estrogen receptor (ER) and AR] are distal
binding factors (7,8). Consistent with the hypothesis
that chromatin looping is a mechanism for interactions
between distal enhancers and proximal promoters (9),
recent studies using chromatin conformation capture
(3C) assay have demonstrated that AR directly
upregulates two canonical androgen-responsive
genes PSA and TMPRSS2 (5,8,10,11). However, the
efﬁciency and the underlying mechanisms for AR-
mediated global long-range regulation are not fully
understood.
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another important ﬁnding from analysis of AR cistrome
and gene expression data is that AR and its cooperating
transcription factor FoxA1 contribute to a subset of AR
target gene expression in a combinatorial fashion (5,12–
15). Furthermore, comparing AR and FoxA1 cistromes
with genome-wide enriched regions of histone H3 lysine
4 di-methylation (H3K4me2), an active histone mark
present on both enhancer and promoter regions (16,17),
revealed a signiﬁcant overlapping between H3K4me2
enriched regions and AR/FoxA1 binding regions, suggest-
ing that AR/FoxA1 binding regions are associated with a
permissive chromatin structure (18). Despite these inter-
esting ﬁndings, it is unknown how H3K4me2, AR and
FoxA1 combinatorially contribute to AR-mediated
global long-range regulation.
CCCTC-binding factor (CTCF) is a highly conserved
transcription factor that plays important roles in tran-
scriptional activation or repression, enhancer blocking
(EB), genetic imprinting and X chromosome inactivation
(19,20). Consistent with this notion, Chan and Song (21)
found that CTCF acts as an EB insulator for ER, prevent-
ing a remote ER enhancer from activating a promoter
when it is located between these regulatory elements.
Recently, CTCF is proposed to function as an organizer
of global chromatin structure, facilitating its own regula-
tion of essential biological processes such as transcription
and insulation (19,22). Therefore, CTCF may also be
involved in AR-driven long-range gene regulation.
Here, we performed an integrated analysis using four
sets of genome-wide protein-DNA binding data (i.e. AR,
FoxA1 and CTCF cistrome data as well as H3K4me2
ChIP-seq data) to elucidate the regulatory mechanism of
androgen responsive genes in prostate cancer. We selected
to use non-promoter H3K4me2 instead of H3K4me1 as
a representative of enhancers in our analysis due to the
fact that there is a higher fraction of overlapping between
me2 with FoxA1 and AR (18). Among the androgen-
responsive genes is a class of genes that are more highly
expressed compared to the rest. Functional data analysis
shows that genes in this class are signiﬁcantly enriched in
cancer related pathways. Further, these genes are located
in CTCF blocks in which there are also AR/FoxA1
binding sites that overlap with those of H3K4me2. This
suggests that AR-mediated target gene expression requires
CTCF insulated, combinatorial regulation of H3K4me2,
AR and FoxA1. We hypothesize that CTCF blocking
leads to a relatively short but efﬁcient long-range com-
binatorial regulation mechanism. Our study provides
evidence on the importance of interplay between chroma-
tin mark, chromatin organizer and speciﬁc transcription
factors, which will likely help in unraveling the complex
regulatory mechanism of AR.
MATERIALS AND METHODS
Data sources
ChIP-seq data of CTCF-bound genomic sites from HeLa,
Jurkat and CD4
+ T cells are obtained from (23,24). Sites
shared at least one base pair (bp) among the different cells
are considered to be common. ChIP-chip data of CTCF
bound genomic sites from LNCaP cells are obtained from
ref. (25). Genes expression values in LNCaP cells after 4h
of dihydrotestosterone (DHT) (dihydrotestosterone) treat-
ment are obtained from ref. (5). ChIP-chip experiment on
AR and FoxA1 performed on LNCaP cell line are
obtained from (5,12,26). High-throughput proﬁling of
active histone modiﬁcation marker in prostate cancer
cells (H3K4me2 ChIP-seq data from LNCaP after 4h of
DHT) are obtained from (18). Large-scale gene expression
proﬁles in 79 human tissues are obtained from (27).
Expression of genes in LCM-capture epithelial cell popu-
lations representing prostate cancer progression from
benign/normal epithelium to metastatic stage are
obtained from (28).
Binding sites and responsive genes detection
Site Identiﬁcation from Short Sequence Reads (SISSRs) is
used to identify CTCF binding sites (29). The longest
overlapping binding sites in all three cells (i.e. CD4
+ T,
Jurkat and HeLa) are deﬁned as the CTCF-bound
region. Model-based Analysis of Tiling array (MAT) are
used to obtain the FoxA1 and AR binding sites with FDR
cut-off=5% (30). Androgen-responsive genes are deﬁned
as genes that display differential expression after 4h of
DHT treatment with q-values (FDR) less than 0.05. All
gene expression is normalized with RMA (31) and false
discovery rate was calculated using Signiﬁcance Analysis
of Microarrays (SAM) algorithm (32). Note since gene ex-
pression values are obtained from microarray experiment
(5), not all genes in the RefSeq database have gene expres-
sion values. Active histone marker (H3K4me2) enrichment
sites were studied in prostate cancer cells treated with and
without DHT treatment for 4h. Peaks of H3K4me2 en-
richment are determined using Model-based Analysis of
ChIP-Seq (MACS) with P-value cut-off of 10
5 (33).
Overlap between histone markers and transcription
factors are deﬁned as any overlap of at least 1bp.
Statistical analysis
To study distinct mechanisms of AR regulation of
androgen-responsive genes due to different interplay
among transcriptional factors and active histone modiﬁ-
cation (H3K4me2), we performed supervised classiﬁcation
on the androgen responsive genes based on their expres-
sion levels and their relations to the factors including AR,
CTCF, FoxA1 and H3K4me2. Speciﬁcally, these factors
are used to build a logistic regression model: the effects of
distance from genes to transcription factor binding sites
[i.e. distances from transcription start sites (TSS) of
androgen-responsive genes to AR and FoxA1 binding
sites], the role of CTCF as a facilitator (whether AR and
FoxA1 are in the same block) and their overlay with active
histone mark (i.e. whether AR or FoxA1 binding sites
overlap with H3K4me2 region of enrichment.
Operationally, for each gene, the transformed distance
ARDist from TSS to the nearest AR binding site and the
transformed distance FoxA1Dist to the nearest FoxA1
binding site are computed to alleviate severe skewness.
Transformed distance is obtained by subjecting distance
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ARDist, FoxA1Dist, AR (whether AR exist inside the block),
AR-H3K4me2 (whether AR overlap with H3K4me2),
FoxA1 (whether FoxA1 binding site present in the
block) and FoxA1-H3K4me2 (whether FoxA1 overlap
with H3K4me2) are considered initially. We then
selected the best model with the best speciﬁcity and sensi-
tivity in a 5-fold cross validation. Bayes Factor (34) like
criterion was used to classify androgen-responsive genes
based on the ﬁnal logic model.
To compare the sizes of different blocks bounded by
CTCF, we used the Wilcoxon rank sum (i.e. the Mann–
Whitney) test. We chose to use this non-parametric test
instead of the T-test to minimize the effect of outlying
observations since the distributions of the block sizes are
extremely skewed. Likewise, for comparing expression of
genes in different tissues, we used the paired Wilcoxon
rank sum test.
RNA interference
siRNA targeting CTCF (siCTCF) or a control siRNA
(siControl) were purchased from Dharmacon (ON
TARGET plus siRNA), and were transfected into
LNCaP cells using Lipofectamine 2000 (Invitrogen).
Real-time RT–PCR
Real-time RT–PCR was performed as before (10). Brieﬂy,
total RNA was isolated using an RNeasy kit (Qiagen,
Valencia, CA, USA). cDNA was reverse transcribed
from total RNA (1mg) using a High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster
City, CA, USA). Real-time PCR was performed on the
Applied Biosystem TaqMan Array Custom Plate con-
taining 36 responsive genes in CTCF blocks with AR, 24
responsive genes in CTCF block without AR and 4 can-
didate endogenous control genes. TaqMan Fast
Universal PCR Master Mix was used on the
StepOnePlus
TM Real-Time PCR System (Applied
Biosystems) following the manufacturer’s instructions.
All genes examined are listed in Supplementary Table S1.
ChIP
CTCF ChIP assays were performed as previously
described (10,26). The anti-CTCF antibodies (07–729)
were purchased from Millipore. Primer sequences are
listed in Supplementary Table S2.
RESULTS
Common CTCF binding sites
Recent studies have mapped the locations of CTCF
binding sites in CD4, Jurkat and HeLa cell lines (23,24),
with 11553 common sites between the three cells. We
found that these shared CTCF binding sites are mostly
located in intergenic regions (52%) but over 27% are in
intronic regions and many are occupying promoter and
exonic regions (Supplementary Figure S1). These CTCF
sites are also evolutionarily conserved (Supplementary
Method and Supplementary Figure S2), which is shown
by the ﬁgure that conservation scores around the CTCF
binding sites (center of plot) are twice as large as the scores
denoting the genomic background (both ends of plot).
Also, around 59% of these sites overlap with DNase I
hypersensitive zones (see Supplementary Method), which
might indicate that CTCF can partition the genome into
physically distinct domains of gene expression since hyper-
sensitive sites are found in relaxed chromatin in which the
associated gene is active.
Genomic CTCF blocks
In order to study the long-range regulation of
androgen-responsive genes involving AR, together with
other factors such as CTCF, FoxA1 and H3K4me2, we
ﬁrst identiﬁed androgen-responsive genes using expression
levels in LNCaP cell line after 4h of DHT treatment
[a more potent agonist for AR activation than testoster-
one (T)] compared to their basal expression (5). We
identiﬁed a total of 388 androgen-responsive genes (315
upregulated and 73 downregulated) using q-value (FDR)
cut-off of 0.05. Since we focus on androgen-responsive
genes throughout this article, these genes are referred to
as responsive genes (up/down-regulated) hereafter. We
identiﬁed AR and FoxA1 binding sites from ChIP-chip
experiments on LNCaP cell line (5,12,26). We found a
total of 8663 AR binding sites and 20826 FoxA1
binding sites. We also identiﬁed H3K4me2 enrichment
region using ChIP-seq experiment on LNCaP cells (18)
and found a total of 90053 peaks.
Next, we divided the genome into distinct CTCF blocks
to study the combinatorial relationship of AR-mediated
gene expression with other factors within and across dif-
ferent blocks. Since these 11553 common CTCF binding
sites are evolutionary conserved [see Supplementary
Figure S2 and Reference (20)], they are used to partition
the human genome. These sites demarcate the genome
into 11576 blocks of varying sizes with a median of
81kb and an IQR (interquartile range) of 198kb. Here,
a block is deﬁned as a genomic region with two consecu-
tive CTCF-bound sites as borders and include the begin-
ning (ending) of each chromosome to (from) the ﬁrst (last)
binding sites on the chromosome (Figure 1A).
Of the 11576 blocks, 4164 (36%) contain no RefSeq
genes. The remaining 7412 blocks (64%) consist of at
least one RefSeq genes, but 256 blocks have RefSeq
genes that were not included in our gene expression
arrays. This leaves us with 7156 blocks (62%) that
contain at least one RefSeq gene that are on our micro-
array. Of these, a small number of blocks (365 or 5%)
include at least one responsive gene (referred to as re-
sponsive blocks), while 6791 (95%) have only non-
responsive genes (referred to as non-responsive blocks).
Supplementary Table S3 provides a summary of these
four types of blocks.
There are a total of 3669 blocks (32%) containing 8663
AR binding sites (referred to as AR blocks) indicating
many blocks with multiple AR binding sites. For
brevity, we refer to AR binding sites as AR sites. The
remaining 7907 blocks (68%) contains no AR sites.
Among the AR blocks, 296 (8% relative to AR blocks)
4756 Nucleic Acids Research, 2012,Vol.40, No. 11contain at least one responsive gene. These blocks are
referred to as AR block with AR-responsive gene
(AR–ARG), which consist a total of 316 responsive
genes representing 81% of all responsive genes. The
majority of these AR blocks have only one responsive
gene but a few have multiple ones. About 2729 AR
blocks (74%) have RefSeq genes that are all
non-responsive and the remaining 644 AR blocks contain
no RefSeq genes that were studied. Supplementary Table
S4 provides a summary of these AR blocks.
In contrast, there are 5231 blocks (45%) containing
20826 FoxA1 binding sites (referred to as FoxA1
blocks). For brevity, we refer to FoxA1 binding sites as
FoxA1 sites. The remaining 6345 blocks (55%) contains
no FoxA1 sites. Among the FoxA1 blocks, 334 (6%)
contain at least one responsive gene with a total of 354
responsive genes representing 91% of all responsive genes.
About 3804 FoxA1 blocks have RefSeq genes that are all
non-responsive and the remaining 1093 FoxA1 blocks
contain no RefSeq gene that were studied. Supplementary
Table S5 provides a summary of these FoxA1 blocks.
Considering AR, FoxA1 and RefSeq genes jointly,
there are 2620 blocks that contain both AR, and FoxA1
sites and at least one RefSeq genes which were on our
microarray. Of these, 289 blocks (11%) consist of at
least one responsive gene. The remaining 2331 blocks
(89%) have genes that are all non-responsive. Supple-
mentary Table S6 provides a summary on these and
other types of combined blocks. As can be seen from
Supplementary Tables S2 and S4, out of the 296 AR
blocks with at least one responsive gene, 98% (289) of
these also contain FoxA1 (See supplementary Figure S3
for intersection between AR, FoxA1, responsive genes and
RefSeq genes blocks). This perhaps suggests that almost
all of the responsive genes in AR blocks are co-regulated
by FoxA1.
It is interesting to note that AR blocks with responsive
genes (median=396kb and IQR=553kb) are signiﬁ-
cantly longer than AR blocks with only non-responsive
genes (median=302kb and IQR=480kb) (Mann–
Whitney test, P-value=1.5010
5), which appears to
support the theory that AR regulates genes via long-range
interaction (8,35). As such, AR blocks with responsive
genes are longer than AR blocks with genes that are not
being regulated by AR. Figure 1B shows the distribution
of different types of blocks.
Figure 1. (A) Cartoon illustration of various blocks. Bar: CTCF binding sites; rectangle: AR binding site; hexagon: FoxA1 binding site; line:
H3K4me2 enrichment site. A genomic region with CTCF binding sites as borders is deﬁned as a block. The ﬁrst block from the left containing
a RefSeq gene, AR binding site and H3K4me2 enrichment is both an AR block and a H3K4me2 block. The second block is referred to as FoxA1
block since it contains only FoxA1 binding site. The last block is both an AR-H3K4me2 block (AR binding site overlap with H3K4me2 enrichment)
and a FoxA1 block. (B) Distribution of length of blocks in kb. In addition to the overall distribution, the ﬁgure also shows the distribution of blocks
containing AR binding sites (AR blocks), blocks containing FoxA1 (FoxA1 blocks), blocks containing at least one responsive genes (responsive
blocks), and blocks consist of only non-responsive genes (non-responsive genes) in LNCaP cell line 4h after being induced by androgen.
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androgen-responsive genes
CTCF has been touted as an enhancer insulator in the
literature. For example, Chan and Song (21) provided
some evidence that CTCF can block distal action of ER.
We set out to ﬁnd whether CTCF has a similar role in
relation to AR by trying to obtain answers to the follow-
ing questions: Does AR potentially regulate genes in
the same block? Can AR also regulate genes in nearby
blocks? To this end, we compared the log fold change of
the expression levels of all genes in ‘AR-ARG blocks’ to
the log fold change of the expression of all genes in
‘nearby-no-AR blocks’ (i.e. blocks nearest to AR-ARG
blocks but not containing AR themselves). The log fold
change is computed from the expression levels of genes
after 4-h of DHT stimulation versus vehicle control.
To exclude genes that are too far to be regulated by AR,
we ﬁlter out genes that are more than 100kb away
from any AR binding site. We have 1064 total genes in
296 ‘AR-ARG blocks’ and 71 total genes in 58
‘nearby-no-AR blocks’. Figure 2A provides an illustration
of the genes in the two types of blocks being compared
(i.e. all genes in ‘AR-ARG blocks’ versus all genes in
‘nearby-no-AR blocks’). Figure 2B shows that the
change of expression levels of all genes in ‘AR-ARG
blocks’ is signiﬁcantly higher than genes located in
‘nearby-no-AR blocks’ (Mann–Whitney test, P-
value=1.4210
5). Figure 2C shows the individual
gene expression fold change in ‘upAR-ARG blocks’ (red
bar, ‘AR blocks with up-regulated gene’), ‘downAR-ARG
blocks’ (green bar, ‘AR blocks with down-regulated
gene’) and in ‘nearby-no-AR blocks’ (black bar, ‘blocks
without AR nearest to AR-ARG blocks’). Although there
are some responsive genes, in general genes in
‘nearby-no-AR blocks’ do not show differential expres-
sion (with black lines spread out through the entire
range), whereas genes in ‘upAR-ARG blocks’ and in
‘downAR-ARG blocks’ mostly show high and low expres-
sion level, respectively. This indicates that distal AR may
regulate genes within the same ‘CTCF block’. Consistent
with this notion, we have experimentally demonstrated
that 4 distal AR binding sites located at 12kb, 14kb,
20kb and 73kb away from transcription start site
(TSS) of TMPRSS2 gene form chromatin loops with the
TMPRSS2 promoter within the same CTCF block (10).
We have also observed responsive genes that do not
have AR binding sites in the same block. However, we
found the expression fold changes of the 316 responsive
genes in blocks with AR are signiﬁcantly higher than the
72 responsive genes in blocks without AR (Figure 2D,
Mann–Whitney test, P-value=4.4410
4). To experi-
mentally validate these ﬁndings and investigate whether
CTCF binding affects the expression of responsive genes
in blocks with AR and without AR, we have now
examined expression of a subset of the responsive genes
(60 genes) after CTCF silencing in LNCaP cells by using
real-time RT–PCR. As expected, silencing of CTCF sig-
niﬁcantly decreased CTCF protein expression (Figure 2E)
and CTCF binding at selected CTCF blocks with or
without AR (Figure 2F). Consistent with gene expression
microarray results (Figure 2D), expression fold changes of
responsive genes in blocks with AR were signiﬁcantly
higher than responsive genes in blocks without AR
in control silenced cells (Figure 2G, Mann–Whitney test,
P-value=3.2410
9). Importantly, while silencing of
CTCF does not lead to appreciable fold changes of the
responsive genes in blocks without AR (Figure 2G,
P-value=0.20), knocking down of this transcription
factor signiﬁcantly decreased expression fold changes
of responsive genes in blocks with AR (Figure 2G,
P-value=1.6110
4), suggesting that CTCF facilitates
AR regulation of target genes within the same block.
Since AR binding sites and the TSSs of most responsive
genes within the same CTCF blocks can be separated by
more than 4kb, this lead to the hypothesis of a relatively
short but efﬁcient long-range AR regulation mechanism
facilitated by CTCF blocking.
Supervised classiﬁcation of androgen-responsive genes
further supports the hypothesis of short combinatorial
long-range regulation
As shown in the previous section, not all responsive genes
have AR binding sites in the same CTCF block. This leads
to the hypothesis of two distinct mechanisms of AR regu-
lation of responsive genes due to different interplay among
transcriptional factors and active histone modiﬁcation
(H3K4me2). Indeed, analysis based on the logistic regres-
sion model selection and classiﬁcation strategy as
described in methods section reveals two distinct classes
of responsive genes. Our results show that these classiﬁca-
tions are determined by their distances to the AR and
FoxA1 binding sites, whether the gene is in an ‘AR
block’, and whether there is an overlap between AR and
H3K4me2 enriched regions. Class 1 contains mainly re-
sponsive genes that are close to AR and FoxA1 binding
sites (median distance from TSS to AR and FoxA1
binding sites are 12 and 7.6kb, respectively; Table 1)
and with most genes (94%) having AR/H3K4me2
overlapping region within the same CTCF block. On the
other hand, Class 2 contains responsive genes that are
farther away from AR and FoxA1 binding sites (median
distance from TSS to AR and FoxA1 binding sites are 96
and 54kb, respectively; Table 1) and only a small percent-
age of genes (24%) have AR/H3K4me2 overlapping
region within the same block. These characterizations of
the two classes are based on the logit model (left panel
of Table 1). In addition, as shown in Table 1, almost all of
the genes (93%) in Class 1 has an AR/H3K4me2
overlapping region and also FoxA1 binding sites in the
same block compared to Class 2 that have only around
22% showing such overlap (right panel of Table 1).
The two classes indicate two distinct mechanisms of
long-range regulation of androgen-responsive genes. In
particular, genes in Class 1 correspond to ‘short’ combina-
torial long-range regulation that we have hypothesized,
whereas the long-range regulation mechanism of genes
in Class 2 is less clear, although it is consistent with a
long-range regulation mechanism that requires mediation
from factor(s) that are located much farther away from
the genes being regulated. To elaborate on the effect of
4758 Nucleic Acids Research, 2012,Vol.40, No. 11Figure 2. Genes with AR in the same block exhibit higher levels of gene expression fold change. (A) Illustrations of two types of blocks that are
being compared in (B). AR-ARG block is deﬁned as block with both AR binding site (purple box) and androgen-responsive gene (purple arrow).
Nearby non-AR block is deﬁned as block adjacent to AR-ARG blocks without AR binding site. (B) Expression fold-change of all genes in AR-ARG
blocks (blocks with androgen-responsive gene and AR binding site) are signiﬁcantly higher than genes in nearby non-AR blocks. (C) Heatmap
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(continued)distances on the classiﬁcation of these two classes, we
plotted the density function (smoothed using spline
function) of the distances, stratiﬁed according to classes
and up/down regulation of genes (Figure 3). As shown in
Figure 3, genes in Class 1 are closer to AR and FoxA1
binding sites compared to those in Class 2 with both up-
and down-regulated genes showing similar patterns. This
phenomenon is more obviously displayed in upregulated
genes.
Interestingly, genes in Class 1 shows signiﬁcantly higher
change of expression level compared to genes in Class 2
(Mann–Whitney, P-value=4.3410
10), with around
93% of the genes in Class 1 having AR/H3K4me2
overlapping region as well as having FoxA1 binding
sites in the same CTCF blocks (Figure 4). Our analysis
thus suggests that higher expression level may be due to
short combinatorial long-range regulation being much
more efﬁcient than other mechanisms of long-range regu-
lation. We next provide three lines of evidence to support
our observation and conclusion using existing data and
resources/databases, as we detail in the following sections.
Functional analysis of classiﬁed androgen-responsive genes
Three lines of evidence are shown to substantiate the
ﬁnding that ‘short’ combinatorial long-range regulation
is much more efﬁcient than other long-range regulation.
First, we performed KEGG pathway analysis to show that
Class 1 is signiﬁcantly enriched in prostate cancer related
genes. Second, we showed that the genes in Class 1
are preferentially expressed in prostate tissues. Finally,
we assess the biological signiﬁcance of the set of genes
in Class 1 on cells isolated using laser-capture
microdissection (LCM) representing prostate cancer
progression.
Genes in Class 1 are enriched in cancer related pathway. In
order to assess the biological signiﬁcance of the two classes
identiﬁed using supervised classiﬁcation, we performed
KEGG pathway analysis (Table 2). Genes in Class 1 dem-
onstrate a signiﬁcant enrichment in cancer and prostate
cancer pathways with P-values=0.0009 and 0.0015, re-
spectively. In contrast, genes in Class 2 do not show en-
richment in cancer pathway in general nor prostate cancer
in particular. Instead they show enrichment in Focal
adhesion pathway, among others (Table 2).
Preferential expression of Class 1 in prostate tissues. We
further substantiate our ﬁnding in prostate tissues by con-
sidering the microarray data published in (27). There were
a total of 79 tissue types, with one being prostate tissue
and the remaining being other tissues. Each tissue type has
two samples. We performed statistical analysis to investi-
gate whether genes in either or both classes deﬁned previ-
ously are preferentially expressed in the prostate tissue
compared to the other tissues. Our results reveal that
genes in Class 1 indeed exhibit much higher difference of
expression level in prostate tissues. Speciﬁcally, we
demonstrated that the levels of expression for genes in
Class 1 are much higher in prostate cells (Figure 5;
Paired Wilcoxon rank test, P-value=2.210
16)
compared to the other tissues types. Although genes in
Class 2 also exhibit higher levels of expression in
prostate cells (paired Wilcoxon rank test,
P-value=2.1510
8) compared to the other tissues,
their magnitudes differ (P-value of 10
16 versus P-value
of 10
8). Taken together, this shows that genes in both
Figure 2. Continued
showing the log2 fold-change of expression level of all genes in nearby non-AR blocks (black bar), genes in upAR-ARG blocks (blocks with
upregulated androgen-responsive gene and AR, red bar) and genes in downAR-ARG blocks (blocks with downregulated androgen-responsive genes
and AR, green bar). Color represents log2 fold-change of expression level of genes after 4h DHT versus 0hr DHT (basal level). (D) Expression
level of androgen-responsive genes in AR blocks are signiﬁcantly higher than those in blocks without AR (non-AR blocks). (E) Silencing of CTCF
decreases CTCF protein expression. LNCaP cells were transfected with siControl or siCTCF, and treated with vehicle or DHT for 4h. Western blots
were performed using antibodies indicated. (F) Silencing of CTCF decreases CTCF binding at the CTCF blocks with AR (regions 1–4) and
without AR (regions 5–6). LNCaP cells were transfected with siControl or siCTCF, and stimulated with vehicle or DHT. ChIP assays were
performed using antibodies against CTCF. (G) Silencing of CTCF signiﬁcantly decreases expression fold changes of responsive genes in blocks
with AR. siControl or siCTCF transfected LNCaP cells were stimulated with vehicle or DHT for 4h. Total RNA was isolated and ampliﬁed with
gene-speciﬁc primers.
Table 1. Characteristics of genes in the two classes
Model characteristics Implications
AR (%) ARDist (kb) FoxA1Dist (kb) AR-H3K4me2 (%) FoxA1 (%) AR-H3K4me2+FoxA1 (%)
Class 1 98 12 7.6 94 97 93
Class 2 38 96 54 24 76 22
The left panel, ‘Model characteristics’, shows signiﬁcant factors identiﬁed from the supervised classiﬁcation model. The right panel displays two
factors that were not included in the model but are indirectly implied from the classiﬁcation of the two classes. AR: percentage of genes which have
AR in the same block, ARDist: median distance (in kb) from the TSS of genes to the nearest AR binding sites, FoxA1Dist: median distance (in kb)
from the TSS of genes to the nearest FoxA1 binding sites. AR-H3K4me2: percentage of genes which have AR binding site that overlap with
H3K4me2 enrichment in the same block, FoxA1: percentage of genes which contain FoxA1 in the same block, AR-H3K4me2+FoxA1: percentage of
genes which have AR binding sites that overlap with H3K4me2 enrichment as well as FoxA1 binding site in the same block.
4760 Nucleic Acids Research, 2012,Vol.40, No. 11classes are preferentially expressed in prostate tissues, but
with Class 1 having higher difference in expression than
Class 2 (Figure 5). The fact that genes in both classes show
greater activity in prostate tissues is not surprising; as both
classes contain responsive genes. However, the observa-
tion that genes in Class 1 exhibit greater changes of ex-
pression in prostate tissues than those in Class 2 suggest
that Class 1 genes might play a more important role than
Class 2 genes in the growth and maintenance of the
prostate.
Class 1 genes are related to prostate cancer
metastasis. Finally, we evaluated the biological signiﬁ-
cance of the genes (focusing on Class 1) for prostate
cancer progression. We assess the expression of these
genes in the analysis of LCM (Laser Capture
Microdissection) epithelial cell populations representing
prostate cancer progression from benign epithelium to
metastatic disease (28). Interestingly, genes in Class 1
show a similar pattern in benign/normal epithelial, PIN
(prostatic intra epithelial neoplasia), and localized
Figure 3. Genes in Class 1 are closer to a transcription factor AR and to FoxA1 binding sites compared to genes in Class 2. The same patterns are
observed in both up- and down-regulated genes, although this distance preferential are more obvious for over-expressed genes.
Figure 4. Comparison of genes in Class 1 and Class 2 in terms of expression level and block classiﬁcation. (A) Genes in Class 1 exhibit higher change
of expression level than those in Class 2. (B) 93% of genes in Class 1 have AR binding sites which overlap with H3K4me2 as well as having FoxA1
bindings in the same CTCF block. In contrast, only 22% of genes in Class 2 have AR overlap with H3K4me2 and FoxA1 in the same block.
Nucleic Acids Research, 2012,Vol.40, No. 11 4761prostate cancer, but a distinctive pattern in metastatic
prostate cancer (Figure 6, left panel). In contrast, genes
in Class 2 show similar patterns in all categories (Figure 6,
right panel). Since Class 1 is more responsive to androgen,
our ﬁnding that these genes are more reduced in metastatic
samples compared to Class 2 is consistent with previous
ﬁndings that androgen signaling activity is decreased in
metastatic prostate cancer (28). The distinctive pattern in
metastatic prostate cancer for Class 1 genes indicates their
promising potential as novel biomarkers in delineating
metastatic prostate cancer. Speciﬁcally, genes in Class 1
that are highly expressed and are hypothesized to be
involved in ‘short’ combinatorial long-range regulation
were downregulated in metastatic versus localized
prostate cancer.
DISCUSSION
The mechanisms by which transcription factors regulate
distally located genes have become one of the most
intriguing topics in recent years. Transcription factors
such as AR, FoxA1, CTCF and H3K4me2 (an active
histone mark) are all believed to play an important role
in gene regulation. Such factors are likely to act in concert
rather than independently, and thus it is hypothesized that
understanding of the combinatorial effects of known gene
regulators would lead to unraveling of the complexity of
long-range regulation mechanism. To the best of our
knowledge, the interacting effects of individual regulators
have not been studied previously, which is the challenge
that we have taken up in this article.
Our statistical analysis and experimental exploration
showthatCTCFcanactasafacilitatorwhereARregulation
within CTCF blocks is more effective than across blocks.
Thisisconsistentwithourpreviousﬁndingthatinsertingthe
chicken b-globin insulator core fragment FII containing
CTCF binding sequence between the PSA gene enhancer
and promoter signiﬁcantly decreases the PSA reporter
gene expression, suggesting that CTCF can function as an
insulator to block AR target gene expression (11).
We have also performed genome-wide integrated
analysis using all factors jointly followed by supervised
classiﬁcation, which enabled us to discover a subset of
androgen-responsive genes. Almost all of the genes
(93%) in this set have AR/H3K4me2 overlapping region
and FoxA1 binding sites located in the same CTCF block.
Furthermore, they are much closer to AR and FoxA1
binding sites compared to other androgen responsive
genes (median distances to AR and FoxA1 binding sites
are 12kb and 7.6kb versus 96kb and 54kb). Genes in
this subset also show higher preferential expression in
prostate tissues and are enriched in prostate cancer and
cancer related pathways. Furthermore, these genes were
downregulated in metastatic versus localized prostate
cancer. Thus, our result reveals for the ﬁrst time that
AR target genes under CTCF-facilitated ‘short’ combina-
torial long-range control may play more important roles
in prostate development and prostate cancer progression
than those genes under ‘long’ long-range control.
Table 2. Top functional terms for genes within the two classes obtained using supervised classiﬁcation method
Class 1 Class 2
Pathway P-value Pathway P-value
Pathways in cancer 0.0009 Focal adhesion 0.0115
B-cell receptor signaling pathway 0.0009 TGF-beta signaling pathway 0.0115
Type II diabetes mellitus 0.0009 Bladder Cancer 0.0143
Steroid biosynthesis 0.0009 O-Glycan biosynthesis 0.0143
Adipocytokine signaling pathway 0.0009 Cytokine-cytokine receptor interaction 0.0143
Neuroactive ligand-receptor interaction 0.0009 Cell adhesion molecules (CAMs) 0.0143
Prostate cancer 0.0015 Arginine and proline metabolism 0.0173
P53 signaling pathway 0.0041 mTOR signaling pathway 0.0173
endocytosis 0.0041 VEGF signaling pathway 0.0212
Neurotrophin signaling pathway 0.0042 P53 signaling pathway 0.0212
Benjamini–Hochberg corrected P-values are noted. Categories that are cancer related are in bold.
Figure 5. Genes in Class 1 are preferentially expressed in prostate cells
compared to other tissues. Genes in Class 1 exhibit signiﬁcantly higher
expression level in prostate compared to other tissues (paired Wilcoxon
test, P-value=2.210
16). Genes in Class 2 also show signiﬁcantly
higher expression level in prostate cells versus the remaining tissues
(paired Wilcoxon test, P-value=2.1510
8).
4762 Nucleic Acids Research, 2012,Vol.40, No. 11Fullwood et al. (36) developed a new method called
ChIA-PET (chromatin interaction analysis by paired-end
tag) to detect global chromatin looping mediated by a
speciﬁc protein. Their results suggest that many ER-a
binding sites interact with gene promoters through
long-range chromatin looping. Studying the same issue
but from a different angle, our results indicates that
AR-mediated regulation appear to be similar to ER in
that many genes are regulated through a remote mechan-
ism. Most interestingly, for the ﬁrst time, our results shed
new lights on long-range regulation mechanisms by
showing that AR-mediated long-range regulation may
involve short chromatin loops with a number of factors
including histone modiﬁcation marks, and that such short
combinatorial long-range regulation may be more efﬁcient
than other long-range regulation mechanisms.
Recently, a new CTCF ChIP-chip experiment in
LNCaP cells covering chromosomes 8, 11 and 12 was
carried out by (25). We found CTCF binding sites dis-
covered in their experiments have huge overlap with the
CTCF ChIP-seq data that we are using. More than 80%
of the CTCF in LNCaP cells (fdr<10%) overlapped with
the CTCF in Jurkat, CD4+ T and HeLa cells on those
three chromosomes. In this article, we decided to use the
shared CTCF binding sites found in the three cells because
of their large overlap with CTCF binding sites in LNCaP.
Furthermore, CTCF experiment in LNCaP only has
limited coverage (only done on 3 chromosomes). In the
future, as more data become available, it would be useful
to conﬁrm our ﬁndings using additional genome-wide
CTCF bound data in LNCaP.
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